Avian influenza vaccines: what's all the flap?

被引：16

作者：

Sambhara, S ^{[1
]}

Poland, GA

机构：

[1] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA

[2] Mayo Clin, Coll Med, Mayo Vaccine Res Grp, Program Translat Immunovirol & Biodefense, Rochester, MN USA

[3] Mayo Clin, Coll Med, Dept Internal Med, Program Translat Immunovirol & Biodefense, Rochester, MN USA

来源：

LANCET | 2006年 / 367卷 / 9523期

关键词：

D O I：

10.1016/S0140-6736(06)68657-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1636 / 1638

页数：3

共 12 条

[1] Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
Bresson, Jean-Louis
Perronne, Christian
Launay, Odile
Gerdil, Catherine
Saville, Melanie
Wood, John
Hoeschler, Katja
Zambon, Maria C.
[J]. LANCET, 2006, 367 (9523) : 1657 - 1664
[2] *FOOD DRUG ADM CTR, 2006, GUID IND CLIN DAT NE
[3] Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice
Hoelscher, MA
Garg, S
Bangari, DS
Belser, JA
Lu, XH
Stephenson, I
Bright, RA
Katz, JM
Mittal, SK
Sambhara, S
[J]. LANCET, 2006, 367 (9509) : 475 - 481
[4] Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats
Karaca, K
Swayne, DE
Grosenbaugh, D
Bublot, M
Robles, A
Spackman, E
Nordgren, R
[J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (11) : 1340 - 1342
[5] Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
Nicholson, KG
Colegate, AE
Podda, A
Stephenson, I
Wood, J
Ypma, E
Zambon, MC
[J]. LANCET, 2001, 357 (9272) : 1937 - 1943
[6] Vaccines against avian influenza - A race against time.
Poland, GA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13) : 1411 - 1413
[7] ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus
Rimmelzwaan, GF
Claas, ECJ
van Amerongen, G
de Jong, JC
Osterhaus, ADME
[J]. VACCINE, 1999, 17 (11-12) : 1355 - 1358
[8] Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function
Sambhara, S
Kurichh, A
Miranda, R
Tumpey, T
Rowe, T
Renshaw, M
Arpino, R
Tamane, A
Kandil, A
James, O
Underdown, B
Klein, M
Katz, J
Burt, D
[J]. CELLULAR IMMUNOLOGY, 2001, 211 (02) : 143 - 153
[9] Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
Treanor, JJ
Campbell, JD
Zangwill, KM
Rowe, T
Wolff, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13) : 1343 - 1351
[10] Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
Treanor, JJ
Wilkinson, BE
Masseoud, F
Hu-Primmer, J
Battaglia, R
O'Brien, D
Wolff, M
Rabinovich, G
Blackwelder, W
Katz, JM
[J]. VACCINE, 2001, 19 (13-14) : 1732 - 1737

← 1 2 →